Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB18744InvestigationalSmall molecule
Glecirasib: Overview.
- Mechanism
- Curator reviewed
Pharmacologically active on GTPase KRas
- Formula / weight
- C31H26ClF4N7O2 · 640.04 g/mol (avg)
- Code names
- JAB-21822
Resolves to
Compound
Structure
InChIKey
QRRJEUIQLZNPIO-UHFFFAOYSA-NSMILESCC(C)C1=NC=CC(C)=C1N1C(=O)C(C#N)=C(N2CCN(CC2)C(=O)C=C)C2=CC(Cl)=C(N=C12)C1=C(N)C(F)=C(F)C(F)=C1FTargets
What you can answer from here — as of July 09, 2026
Which drugs share a target with Glecirasib, and which of those have an active Phase 3 trial?